Apella Capital’s Minerva Neurosciences NERV Stock Holding History

Apella Capital’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$138K	Hold	42,250	–	–	﹤0.01%	760
2026 Q2	$202K	Hold	42,250	–	–	﹤0.01%	673
2026 Q1	$284K	Sell	42,250 -130	-0.3%	-$746	﹤0.01%	571
2025 Q4	$170K	Buy	42,380 +3,066	+8%	+$11.4K	﹤0.01%	521
2025 Q3	$99.5K	Buy	39,314 +18,375	+88%	+$37.6K	﹤0.01%	467
2025 Q2	$34.3K	Buy	20,939 +314	+2%	+$513	﹤0.01%	420
2025 Q1	$27.6K	Buy	+20,625	New	+$40.7K	﹤0.01%	384

Other funds holding NERV

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Apella Capital's NERV Position: Q3 2026 in Review

Apella Capital held its Minerva Neurosciences (NERV) position steady in Q3 2026 at 42,250 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Apella Capital first reported a position in NERV in Q1 2025 and has held it in 7 quarters since. The position peaked at $284K in Q1 2026. 9 funds tracked by Wall St. Rank hold NERV as of Q3 2026.

Apella Capital held 42,250 shares of Minerva Neurosciences worth $138K as of Q3 2026.
Apella Capital left its Minerva Neurosciences share count unchanged in Q3 2026.
Minerva Neurosciences made up ﹤0.01% of Apella Capital's portfolio in Q3 2026, its #760 holding.
Apella Capital first reported a position in Minerva Neurosciences in Q1 2025 and has held it in 7 quarters since.
Apella Capital's Minerva Neurosciences position peaked at $284K in Q1 2026.
9 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.